Sentient’s Tixel Receives FDA Nod for Treatment of Periorbital Wrinkles

When briefly applied to the skin, the device transfers thermal energy directly to its top layers, creating controlled micro-damage that stimulates collagen production and rejuvenates the skin's appearance.

The device combines heat with the forward motion of a medical-grade titanium tip.

The U.S. Food and Drug Administration has approved Tixel by Sentient for the treatment of periorbital wrinkles.

Tixel by Sentient delivers short bursts of thermal energy into the skin's surface without damaging the deeper tissues. The device combines heat with the forward motion of a medical-grade titanium tip. When briefly applied to the skin, the device transfers thermal energy directly to its top layers, creating controlled micro-damage that stimulates collagen production and rejuvenates the skin's appearance. 

Tixel by Sentient does not emit radiation, eliminating the need for laser-impenetrable metal ocular shields or eye shields typically used during laser treatments to protect sensitive areas. 

Makeup can be applied the day after treatment, and pain and downtime are minimal compared to laser and radio frequency treatments, according to Sentient.

"The FDA's approval for treating periorbital wrinkles with Tixel by Sentient is a game-changer for patients and for the aesthetics industry," says Chris Cella, chief executive officer of Sentient, in a news release. "It reaffirms Sentient's dedication to innovation and delivering safe and effective outcomes for our patients. We look forward to continuing our mission of enhancing beauty and boosting confidence with our advanced aesthetic care technologies."